Forest Laboratories to Discontinue Namenda Tablets, Focus on Once-Daily Namenda XR
Forest has notified the U.S. Food and Drug Administration of this decision. The oral solution of NAMENDA and once-daily NAMENDA XRA extended-release capsules will continue to be available.
No comments:
Post a Comment